BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1301 related articles for article (PubMed ID: 20236688)

  • 41. Phaeochromocytoma, new genes and screening strategies.
    Gimenez-Roqueplo AP; Lehnert H; Mannelli M; Neumann H; Opocher G; Maher ER; Plouin PF;
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):699-705. PubMed ID: 17121518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
    Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
    Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.
    Erlic Z; Rybicki L; Peczkowska M; Golcher H; Kann PH; Brauckhoff M; Müssig K; Muresan M; Schäffler A; Reisch N; Schott M; Fassnacht M; Opocher G; Klose S; Fottner C; Forrer F; Plöckinger U; Petersenn S; Zabolotny D; Kollukch O; Yaremchuk S; Januszewicz A; Walz MK; Eng C; Neumann HP;
    Clin Cancer Res; 2009 Oct; 15(20):6378-85. PubMed ID: 19825962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and molecular progress in hereditary paraganglioma.
    Baysal BE
    J Med Genet; 2008 Nov; 45(11):689-94. PubMed ID: 18978332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas.
    Krawczyk A; Hasse-Lazar K; Pawlaczek A; Szpak-Ulczok S; Krajewska J; Paliczka-Cieślak E; Jurecka-Lubieniecka B; Roskosz J; Chmielik E; Ziaja J; Cierpka L; Peczkowska M; Preibisz A; Januszewicz A; Otto M; Jarzab B
    Endokrynol Pol; 2010; 61(1):43-8. PubMed ID: 20205103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
    Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
    Baysal BE; Maher ER
    Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant head and neck paragangliomas in SDHB mutation carriers.
    Boedeker CC; Neumann HP; Maier W; Bausch B; Schipper J; Ridder GJ
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):126-9. PubMed ID: 17599579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.
    Gaal J; Burnichon N; Korpershoek E; Roncelin I; Bertherat J; Plouin PF; de Krijger RR; Gimenez-Roqueplo AP; Dinjens WN
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1274-8. PubMed ID: 19915015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [From gene to disease; from SDHD, a defect in the respiratory chain, to paragangliomas and pheochromocytomas].
    Taschner PE; Bröcker-Vriends AH; van der Mey AG
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2188-90. PubMed ID: 12467161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.
    Astuti D; Latif F; Dallol A; Dahia PL; Douglas F; George E; Sköldberg F; Husebye ES; Eng C; Maher ER
    Am J Hum Genet; 2001 Jul; 69(1):49-54. PubMed ID: 11404820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes
    Andrews KA; Ascher DB; Pires DEV; Barnes DR; Vialard L; Casey RT; Bradshaw N; Adlard J; Aylwin S; Brennan P; Brewer C; Cole T; Cook JA; Davidson R; Donaldson A; Fryer A; Greenhalgh L; Hodgson SV; Irving R; Lalloo F; McConachie M; McConnell VPM; Morrison PJ; Murday V; Park SM; Simpson HL; Snape K; Stewart S; Tomkins SE; Wallis Y; Izatt L; Goudie D; Lindsay RS; Perry CG; Woodward ER; Antoniou AC; Maher ER
    J Med Genet; 2018 Jun; 55(6):384-394. PubMed ID: 29386252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?
    Jiménez C; Cote G; Arnold A; Gagel RF
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2851-8. PubMed ID: 16735498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma.
    Montani M; Schmitt AM; Schmid S; Locher T; Saremaslani P; Heitz PU; Komminoth P; Perren A
    Endocr Relat Cancer; 2005 Dec; 12(4):1011-6. PubMed ID: 16322339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types.
    Gill AJ; Chou A; Vilain R; Clarkson A; Lui M; Jin R; Tobias V; Samra J; Goldstein D; Smith C; Sioson L; Parker N; Smith RC; Sywak M; Sidhu SB; Wyatt JM; Robinson BG; Eckstein RP; Benn DE; Clifton-Bligh RJ
    Am J Surg Pathol; 2010 May; 34(5):636-44. PubMed ID: 20305538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pediatric paraganglioma: an early manifestation of an adult disease secondary to germline mutations.
    Mora J; Cascón A; Robledo M; Catala A
    Pediatr Blood Cancer; 2006 Nov; 47(6):785-9. PubMed ID: 16304664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
    Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
    Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas.
    Dahia PL;
    Ann N Y Acad Sci; 2006 Aug; 1073():208-20. PubMed ID: 17102089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
    Gimenez-Roqueplo AP; Dahia PL; Robledo M
    Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetics of pheochromocytoma and paraganglioma in Spanish patients.
    Cascón A; Pita G; Burnichon N; Landa I; López-Jiménez E; Montero-Conde C; Leskelä S; Leandro-García LJ; Letón R; Rodríguez-Antona C; Díaz JA; López-Vidriero E; González-Neira A; Velasco A; Matias-Guiu X; Gimenez-Roqueplo AP; Robledo M
    J Clin Endocrinol Metab; 2009 May; 94(5):1701-5. PubMed ID: 19258401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.